Sun Pharma Acquisition: Sun Pharma to acquire US-based Organon in $11.75 billion deal, among biggest overseas buys by Indian firms
Sun Pharmaceutical Industries on Monday announced it will acquire US-based Organon & Co. in an all-cash deal valued at $11.75 billion, marking one of the largest overseas acquisitions by an Indian company.Under the definitive agreement, Sun Pharma will buy all outstanding shares of Organon at $14 per share.The deal, approved by the boards of both…